2. Inflammation/Immunology

Inflammation/Immunology

Inflammation/Immunology

Related Products

PDF 93.1 MB

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-U00275
    COX-2-IN-1 787623-48-7 98%
    COX-2-IN-1 is potent and slective COX-2 inhibitor with an IC50 of 3.9 μM.
    COX-2-IN-1
  • HY-U00305
    Cicloxilic acid 57808-63-6 98%
    Cicloxilic acid is a biologically active agent.
    Cicloxilic acid
  • HY-U00412
    Asthma relating compound 1 120165-51-7 98%
    Asthma relating compound 1 is an anti-asthmatic agent candidate extracted from patent EP0295656A1.
    Asthma relating compound 1
  • HY-101831
    Heterocyclyl carbamate derivative 1 168830-01-1 98%
    Heterocyclyl carbamate derivative 1 is a heterocyclyl carbamate derivative that may be used for the research of inflammatory and neurological diseases.
    Heterocyclyl carbamate derivative 1
  • HY-19205A
    CMI-392 193739-23-0 98%
    CMI-392 is a dual 5-lipoxygenese inhibitor and platelet-activating factor (PAF) receptor antagonist with IC50s of 100 and 10 nM, respectively.
    CMI-392
  • HY-P0240A
    Tuftsin diacetate 72103-53-8 98%
    Tuftsin diacetate, a tetrapeptide, is a macrophage/microglial activator.
    Tuftsin diacetate
  • HY-U00040
    PAF-AN-1 115621-84-6 98%
    PAF-AN-1 is a platelet activating factor receptor (PAF) antagonist.
    PAF-AN-1
  • HY-U00088
    3β,7β,17β-Trihydroxyandrost-5-ene 2697-85-0 98%
    3b,7a,17a-Trihydroxyandrost-5-ene is a immune modulator extracted from patent US20030060425.
    3β,7β,17β-Trihydroxyandrost-5-ene
  • HY-U00111
    Timobesone 87116-72-1 98%
    Timobesone is a topical corticosteroid but never marketed.
    Timobesone
  • HY-U00122
    Antiulcer Agent 1 76001-09-7 98%
    Antiulcer Agent 1 is a 2-(3,4-dimethoxyphenyl)ethylamine derivative for oral administration at an exploratory stage of new agent development.
    Antiulcer Agent 1
  • HY-U00132
    Embramine 3565-72-8 98%
    Embramine is a monoethanolamine used as an antihistamine and anticholinergic.
    Embramine
  • HY-U00152
    Aminochlorthenoxazin 3567-76-8 98%
    Aminochlorthenoxazin is an antipyretic and analgesic agent.
    Aminochlorthenoxazin
  • HY-U00161
    Betamethasone 17-benzoate 22298-29-9 98%
    Betamethasone 17-benzoate is a representative steroid, which can be used in the treatment of recurrent aphothous ulcers (RAU).
    Betamethasone 17-benzoate
  • HY-U00168
    KP136 76239-32-2 98%
    KP136 (AL136) is an orally effective antiallergic agent. The IC50 is 76.1 μg/mL for histamine release and 63 ug/mL for degranulation.
    KP136
  • HY-U00170
    Bunaprolast 99107-52-5 98%
    Bunaprolast (U66858) is a potent inhibitor of LTB4 production in human whole blood. Bunaprolast (U66858) also exhibits significant inhibition of lipoxygenase and TXB2 release.
    Bunaprolast
  • HY-U00197
    Tilmacoxib 180200-68-4 ≥99.0%
    Tilmacoxib (JTE522) is a highly selective, time-dependent and irreversible human COX-2 inhibitor with an IC50 of 85 nM in an enzyme assay.
    Tilmacoxib
  • HY-U00217
    AZD 4407 166882-70-8 98%
    AZD 4407 is a potent 5-lipoxygenase inhibitor.
    AZD 4407
  • HY-U00222
    S3337 108499-48-5 98%
    S3337 is an H+, K+-ATPase inhibitor.
    S3337
  • HY-U00226
    UP202-56 163838-04-8 98%
    UP202-56 is an adenosine analogue, which is an adenosinergic agonist.
    UP202-56
  • HY-U00235
    SR121566A 180144-61-0 98%
    SR121566A is a novel non-peptide Glycoprotein IIb/IIIa (GP IIb-IIIa) antagonist, which can inhibit ADP-, arachidonic acid- and collagen-induced human platelet aggregation with IC50s of 46±7.5, 56±6 and 42±3 nM, respectively.
    SR121566A
Cat. No. Product Name / Synonyms Application Reactivity